Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Waters posts solid revenue growth but swings to a GAAP loss on acquisition costs.

Risk flags

• ●GAAP EPS swung from $2.47 in Q2 2025 to a loss of ($1.39) in Q2 2026, indicating that acquisition-related charges or other costs are materially impacting reported profitability. This matters because it raises questions about the true economic benefit of the acquisitions and the sustainability of adjusted earnings.
• ●No cash flow, gross margin, or detailed cost disclosures are provided, making it impossible to assess the quality of earnings or the company's ability to convert revenue growth into free cash flow. This lack of transparency increases uncertainty for investors seeking to understand underlying financial health.
• ●The company claims 'all components' of guidance are raised and references 'broad strengthening in end-market conditions,' but provides no supporting numerical evidence for these assertions. This gap between narrative and data introduces a risk that the optimism is not fully grounded in measurable results.
• ●Acquisition-related purchase accounting charges are referenced but not quantified, and the impact on future quarters is not discussed. If these charges persist or integration proves more costly than anticipated, future GAAP profitability could remain under pressure.

Bottom line

Waters Corporation delivered revenue and adjusted EPS growth in Q2 2026, outperforming its own guidance and raising expectations for the remainder of the year. The company’s upbeat narrative is partially supported by realised revenue gains across all major divisions and a 3% increase in adjusted EPS, but the swing to a GAAP loss highlights the material impact of acquisition-related costs. The absence of cash flow, margin, or detailed cost data leaves a significant gap in assessing the sustainability of growth and the true profitability of the business. Investors should view the raised guidance as a positive signal, but the lack of transparency on integration costs and profitability metrics tempers the strength of the story. To materially strengthen the investment case, Waters would need to disclose cash flow and margin trends alongside its headline results. The most important takeaway: revenue momentum is real, but the underlying economics remain unclear without fuller disclosure.

Announcement summary

(NYSE: WAT) Waters Corporation announced its financial results for the second quarter of 2026, reporting total revenue of $1.645 billion, which surpassed the high end of the guidance range. Organic revenue was $828 million, representing 7% growth as reported and 9% in constant currency, while revenue from the acquired Biosciences and Diagnostic Solutions businesses was $817 million, exceeding guidance by $15 million. The Analytical Sciences Division delivered reported revenue of $669 million, the Biosciences Division $368 million, the Advanced Diagnostics Division $449 million, the Clinical Business Unit $72 million, and the Materials Sciences Division $87 million. GAAP diluted loss per share was ($1.39), compared to diluted EPS of $2.47 for the second quarter of 2025, while adjusted EPS grew 3% to $3.05, compared to $2.95 for the second quarter of 2025. The company is raising all components of its full-year 2026 guidance, now expecting organic constant currency revenue growth of 7% to 9%, acquired business reported revenue of $3.045 billion, and adjusted EPS of $14.45 to $14.65, reflecting 10-12% growth. For the third quarter of 2026, Waters expects organic constant currency revenue growth of 8% to 10%, acquired business reported revenue of approximately $895 million, and adjusted EPS of $3.95 to $4.05. Waters Corporation will webcast its second quarter 2026 financial results conference call on August 4, 2026, at 8:00 a.m. Eastern Time.

Disagree with this article?